HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simultaneous novel BCR-ABL gene mutation and increased expression of BCR-ABL mRNA caused clinical resistance to STI571 in double-Ph-positive acute biphenotypic leukemia.

AuthorsMitsuharu Inami, Koiti Inokuchi, Kazutaka Nakayama, Hideto Tamura, Takashi Shimada, Kazuo Dan
JournalInternational journal of hematology (Int J Hematol) Vol. 78 Issue 2 Pg. 173-5 (Aug 2003) ISSN: 0925-5710 [Print] Japan
PMID12953816 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • RNA, Messenger
  • Imatinib Mesylate
Topics
  • Antineoplastic Agents (administration & dosage)
  • Benzamides
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation, Leukemic
  • Genes, abl (genetics)
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, genetics)
  • Male
  • Middle Aged
  • Philadelphia Chromosome
  • Piperazines (administration & dosage)
  • Pyrimidines (administration & dosage)
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: